Navegar

Colección

Datos Estadísticas

Lista de

cancer cell
32
"Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells" (2018) Sampayo, R.G.;Toscani, A.M.;Rubashkin, M.G. (...)Simian, M. Journal of Cell Biology. 217(8):2777-2798
"Metabo-Devo: A metabolic perspective of development" (2018) Gándara, L.; Wappner, P. Mechanisms of Development. 154:12-23
"R-Spondin3 is associated with basal-progenitor behavior in normal and tumor mammary cells" (2018) Tocci, J.M.;Felcher, C.M.;García Sola, M.E. (...)Kordon, E.C. Cancer Research. 78(16):4497-4511
"Phytochemical Study of the Genus Salpichroa (Solanaceae), Chemotaxonomic Considerations, and Biological Evaluation in Prostate and Breast Cancer Cells" (2017) Basso, A.V.;Leiva González, S.;Barboza, G.E. (...)Nicotra, V.E. Chemistry and Biodiversity. 14(8)
"Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity" (2016) Lagadari, M.; Zgajnar, N.R.; Gallo, L.I.; Galigniana, M.D. Molecular Oncology. 10(7):1086-1098
"Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells" (2016) Castillo, L.F.;Tascón, R.;Huvelle, M.A.L. (...)Peters, M.G. Oncotarget. 7(37):60133-60154
"Association of HO-1 and BRCA1 is critical for the maintenance of cellular homeostasis in prostate cancer" (2015) Labanca, E.;De Luca, P.;Gueron, G. (...)De Siervi, A. Molecular Cancer Research. 13(11):1455-1464
"Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases" (2014) Wan, X.;Corn, P.G.;Yang, J. (...)Navone, N.M. Science Translational Medicine. 6(252)
"Differential effect of heterocyclic d-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression" (2014) Gueron, G.;Avanzo, R.E.;Schuster, F. (...)D'Accorso, N.B. Biomedicine and Pharmacotherapy. 68(7):847-854
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Proliferative inhibition and apoptotic mechanism on human non-small-cell lung cancer (A549 cells) of a novel cucurbitacin from Wilbrandia ebracteata cogn" (2013) Silva, I.T.;Teixeira, C.R.;Lang, K.L. (...)Simões, C.M.O. International Journal of Cancer Research. 9(2):54-68
"Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes" (2012) Robaldo, L.;Izzo, F.;Dellafiore, M. (...)Iribarren, A.M. Bioorganic and Medicinal Chemistry. 20(8):2581-2586
"Human periprostatic adipose tissue: Its influence on prostate cancer cells" (2012) Sacca, P.A.;Creydt, V.P.;Choi, H. (...)Calvo, J.C. Cellular Physiology and Biochemistry. 30(1):113-122
"Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein" (2012) Goddio, M.V.;Gattelli, A.;Slomiansky, V. (...)Kordon, E.C. Breast Cancer Research and Treatment. 135(3):749-758
"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320
"Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone" (2011) Alvarez, L.D.;Dansey, M.V.;Martí, M.A. (...)Burton, G. Bioorganic and Medicinal Chemistry. 19(5):1683-1691
"Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation" (2010) Lavaggi, M.L.;Cabrera, M.;Aravena, M.d.l.A. (...)Cerecetto, H. Bioorganic and Medicinal Chemistry. 18(12):4433-4440
"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells" (2009) Gueron, G.;De Siervi, A.;Ferrando, M. (...)Vazquez, E.S. Molecular Cancer Research. 7(11):1745-1755
"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531
"Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment" (2008) Villeneuve, J.;Galarneau, H.;Beaudet, M.-J. (...)Vallières, L. Brain Pathology. 18(3):401-414
"5-Aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells" (2007) Alvarez, M.G.;Lacelli, M.S.;Rivarola, V. (...)Fukuda, H. Journal of Environmental Pathology, Toxicology and Oncology. 26(2):75-82
"Integrating the universe of regulatory cells in cancer. A major hurdle for successful immunotherapy " (2007) Ilarregui, J.M.;Croci, D.O.;Toscano, M.A. (...)Rabinovich, G.A. Medicina. 67(SUPPL 2):25-31
"Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation" (2006) Salatino, M.;Beguelin, W.;Peters, M.G. (...)Elizalde, P.V. Oncogene. 25(59):7723-7739
"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134
"Illudalane sesquiterpenoids from the soft coral Alcyonium paessleri: The first natural nitrate esters" (2000) Palermo, J.A.; Brasco, M.F.R.; Spagnuolo, C.; Seldes, A.M. Journal of Organic Chemistry. 65(15):4482-4486
"Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15" (1998) Ballaré, C.;Portela, P.;Schiaffi, J. (...)Mordoh, J. Breast Cancer Research and Treatment. 47(2):163-170
"Dolichol-sugar derivative synthesis in human breast cancer cell line (T47D). Effects of estrogens and antiestrogens" (1985) Santa Cruz, A.R.; Medrano, E.E.; Baldi, A. Biochemical and Biophysical Research Communications. 126(1):382-388